Laserfiche WebLink
<br /> <br /> <br />80 <br />• Facility Construction <br />o A sink must be available for hand washing. <br />o The lab should have doors to separate the working space with the rest of the facility. <br /> According to the ASPR, BSL-2 laboratories are used to study moderate-risk infectious agents or toxins that pose a <br />moderate danger if accidentally inhaled, swallowed, or exposed to the skin (for example, the flu, HIV, Staph). Design <br />requirements for BSL-2 laboratories include hand washing sinks, eye washing stations, and doors that close and lock <br />automatically. BSL-2 laboratories must also have access to equipment that can decontaminate laboratory waste, <br />including an incinerator, an autoclave, and/or another method of decontamination, depending on the biological risk <br />assessment. <br /> In addition to BSL-1 considerations, BSL-2 laboratories have the following containment requirements: <br />• Laboratory Practices <br />o Access to the laboratory is restricted when work is being conducted. <br />• Safety Equipment <br />o Appropriate PPE is worn, including lab coats and gloves, eye protection and face shields. <br />o All procedures that can cause infection from aerosols or splashes are performed within a biological safety <br />cabinet (BSC). <br />o An autoclave or an alternative method of decontamination is available. <br />• Facility Construction <br />o The laboratory has self-closing doors. <br />o A sink and eyewash are readily available. <br /> The DTPP requires a Biosafety Plan, which will identify biological hazards and identify ways to reduce the health- <br />related risks associated with the biological hazards, to be prepared. A Preliminary Biosafety Plan prepared expands <br />on the containment requirements above with more a detailed example of containment requirements applicable to BSL- <br />1 and BSL-2 uses. When a R&D/Laboratory tenant(s) is identified, a final Biosafety Plan will be prepared, which will <br />identify biological hazard uses specific to the tenant and identify safeguards for protecting against exposure specific <br />to the select agents. <br /> According to San Mateo County Health, there are five (5) categories of Medical Waste as defined in The Medical <br />Waste Management Act (California Health and Safety Code Sections 117600-118360): <br />1. Biohazardous: Red bag waste and infectious contaminated solids <br />2. Sharps: Needles, syringes, blades, and broken glass capable of cutting or piercing <br />3. Pathology: Human body parts, specimens, animals body parts and tissues <br />4. Trace chemotherapeutic waste: Items previously containing chemotherapeutic agents <br />5. Medicine or pharmaceuticals <br /> When a R&D/Laboratory tenant(s) is identified, they will be required to prepare a Medical Waste Management Plan <br />in accordance with the San Mateo County Medical Waste Program that identifies the facility type, medical waste <br />activities, types and amount of regulated medical waste used, types of treatment for medical waste, off site transporter <br />information, plan on how the facility is prepared to manage medical waste spills, employee training, and an emergency <br />action plan. A final Medical Waste Management Plan will be prepared once a tenant has been identified. <br /> According to a preliminary fire evacuation plan, the building would have three interior exit stairs that serve all of the <br />above grade levels. The below grade levels would also have access to three interior exit stairs. The ground floor will <br />have exterior exit doors. These components serve as the primary means of egress in the event of a fire or other <br />emergency that necessitates evacuating the building. Free and unobstructed access to separate, independent exits with <br />adequate spatial separation would be maintained at all times. Laboratories in the building would also have egress doors <br />that provide direct access to exits or access to circulation spaces that lead to these exits. (Meyers+ Engineers, <br />“Preliminary Fire Evacuation Plan – 901 El Camino Real”, September 27, 2023) The final evacuation plan, if <br />R&D/Laboratory tenant(s) is identified, would review future tenant improvements, evaluate the means of egress for <br />laboratories. <br /> In accordance with the DTPP (Sect. 2.2.4.E as presented above), the Redwood City Community Development and <br />Transportation Department, Fire Department, and all required external local, regional, state or federal agencies are <br />required to review and approve or conditionally approve the related safety plans (including the Biosafety Plan, <br />ATTY/RESO.0028/CC RESO CEQA GUIDLINES (920 SHASTA) - EXHIBIT A <br />REV: 04-22-25 VR <br /> <br />Page 80 of 148